Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression.


Journal

The patient
ISSN: 1178-1661
Titre abrégé: Patient
Pays: New Zealand
ID NLM: 101309314

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 30 5 2020
medline: 30 5 2020
entrez: 30 5 2020
Statut: ppublish

Résumé

In the original version of this article, in Fig. 2b the formatting on the x-axis of the graph has been published incorrectly.

Identifiants

pubmed: 32468416
doi: 10.1007/s40271-020-00425-8
pii: 10.1007/s40271-020-00425-8
pmc: PMC7340669
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

469-470

Commentaires et corrections

Type : ErratumFor

Auteurs

Andrea Antinori (A)

HIV/AIDS Department, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.

Maria V Cossu (MV)

1st Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.

Barbara Menzaghi (B)

Infectious Diseases, Azienda Socio-Sanitaria Territoriale della Valle Olona-Busto Arsizio, Busto Arsizio, Italy.

Gaetana Sterrantino (G)

Division of Tropical and Infectious Disease, Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.

Nicola Squillace (N)

Clinic of Infectious Diseases, "San Gerardo" Hospital, ASST Monza, Monza, Italy.

Valentina Di Cristo (V)

DIBIC Luigi Sacco, Division of Infectious Diseases, University of Milan, Milan, Italy.

Annamaria Cattelan (A)

Division of Infectious and Tropical Diseases, Azienda Ospedaliero-Universitaria di Padova, Padua, Italy.

Emanuele Focà (E)

Department of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Brescia, Italy.

Antonella Castagna (A)

Department of Infectious Diseases, IRCSS San Raffaele Scientific Institute, Milan, Italy.
Università Vita-Salute San Raffaele, Milan, Italy.

Giancarlo Orofino (G)

Unit of Infectious Diseases, Amedeo di Savoia Hospital, Turin, Italy.

Daniela Valenti (D)

FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

Gabriella D'Ettore (G)

Department of Public Health and Infectious Disease, Sapienza University, Rome, Italy.

Lucia Aprea (L)

VIII Divisione di Malattie Infettive, A.O.R.N. Cotugno, Naples, Italy.

Sergio Ferrara (S)

Department of Clinical and Experimental Medicine, Infectious Diseases Unit, University of Foggia, Foggia, Italy.

Maria E Locatelli (ME)

UOC Malattie Infettive, ARNAS "Garibaldi", Catania, Italy.

Giordano Madeddu (G)

Unit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Emanuele Pontali (E)

Infectious Diseases, E.O. Ospedali Galliera, Genoa, Italy.

Paolo Scerbo (P)

Unit of Infectious Diseases, "Pugliese-Ciaccio" Hospital, Catanzaro, Italy.

Barbara Rossetti (B)

Infectious Diseases Unit, Siena University Hospital, Siena, Italy.

Alessia Uglietti (A)

Medical Affairs Department, Infectious Diseases, Janssen-Cilag SpA, Via Michelangelo Buonarroti, 23, Cologno Monzese, 20093, Milan, Italy.

Roberta Termini (R)

Medical Affairs Department, Infectious Diseases, Janssen-Cilag SpA, Via Michelangelo Buonarroti, 23, Cologno Monzese, 20093, Milan, Italy.

Francesco Rucci (F)

Department of Oncology and Onco-Hematology, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan, Milan, Italy.

Andrea Gori (A)

Infectious Diseases Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Department of Infectious Diseases, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.

Daniela Mancusi (D)

Medical Affairs Department, Infectious Diseases, Janssen-Cilag SpA, Via Michelangelo Buonarroti, 23, Cologno Monzese, 20093, Milan, Italy. dmancusi@its.jnj.com.

Classifications MeSH